Africa’s brutal experiences battling Ebola and a range of other deadly diseases helped prepare health systems to deal with COVID-19.  And by the time the SARS-CoV2 virus landed on the continent, its Centre for Disease Control (CDC) had already “established regional coordinating centres, increased lab capacity and unified surveillance networks”.  The lessons in emergency response […] Continue reading ->
The COVID-19 pandemic has revealed the profound dangers of having social, economic and health care systems that marginalize public health. To go forward, we must start by looking back. We must build a stronger foundation with better systems that can prevent future pandemics and also weave health into all aspects of society, from our workplaces […] Continue reading ->
Third in a series – Cities are major drivers of public health and the COVID-19 pandemic has brought increasing and urgent necessity for effective, innovative leadership and collaboration within and between cities. “The COVID-19 pandemic has upended lives around the globe and nowhere has the impact of this virus been more evident than in urban areas, […] Continue reading ->
Most shoppers spend less than 10 seconds debating a food choice in the grocery store aisle – and yet choosing processed and low nutrient foods with high levels of sugar, sodium, and fats can lead to chronic diseases, which are expensive to control and often impossible to cure. Now, national regulatory authorities and food companies […] Continue reading ->
The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading ->
On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital.  The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading ->